KMR Group wants to lend a shout out on the appointment of Vasant (Vas) Narasimhan being named as CEO of Novartis. We congratulate him on achieving such an honor and also for retiring CEO Joseph Jimenez’ years of service. It is clear from the tone of the press release and words from the chairman of the board Joerg Reinhardt, retiring CEO Joseph Jimenez, and Vasant Narasimhan that the transition is one of mutual respect, unusual for this day and age and so befitting what we would expect from such high ranking executives. Bravo Novartis for not only developing world class medicines but for also setting an example on how to tastefully pass the torch.
